PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1490249
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1490249
Reproductive Genetics Market size was valued at USD 4878.98 Million in 2023, expanding at a CAGR of 11.9% from 2024 to 2032.
Reproductive genetics is a specialized field focused on understanding how genes influence reproduction, fertility, and inherited disorders. It includes genetic counseling, preimplantation genetic diagnosis (PGD), prenatal genetic testing, carrier screening, reproductive endocrinology, and fertility preservation. The goal is to equip individuals and couples with the knowledge and options needed to make informed family planning decisions while reducing the risk of passing genetic conditions to their offspring.
Reproductive Genetics Market- Market Dynamics
Government educational programs and the recent rise of direct-to-consumer (DTC) testing to propel market demand
Increasing literacy has enhanced the understanding of personal genomic risk. Improved genetic literacy has influenced global public attitudes, understanding, and interest in genetics. Public participation in personal genomics activities, such as research and genomic services, has further increased awareness and understanding of genetics. Additionally, government educational programs and the recent rise of direct-to-consumer (DTC) testing have significantly boosted genomic healthcare knowledge among the population.
Reproductive Genetics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.9% over the forecast period (2024-2032)
Based on procedure type segmentation, carrier screening was predicted to show maximum market share in the year 2023
Based on product type segmentation, kits were the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Reproductive Genetics Market is segmented based on Procedure Type, Product Type, Application, Technology, and Region.
The market is divided into four categories based on Procedure Type: prenatal screening, infertility, preimplantation genetic testing, and carrier screening. The carrier screening segment holds the largest market share during the forecast period. According to the National Human Genome Research Institute, carrier screening involves genetic testing for individuals at risk of passing genetic disorders to their children, even though they do not exhibit any symptoms themselves. The growing risk associated with genetic mutations across ethnicities and the expanded use of genetic testing at early stages has driven the adoption of carrier screening procedures in the market.
The market is divided into four categories based on product Type: kits, reagents and consumables, panels, and systems and instruments. The kits segment is the largest contributor during the forecast period. These kits, used in reproductive genetic testing, include in vitro diagnostic kits developed by companies for commercial purposes, as well as for genetic testing. They are employed in clinical diagnostics, research, and testing applications.
Reproductive Genetics Market- Geographical Insights
Geographically, this market encompasses North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, with participation from multiple nations within each region shaping its landscape. North America is the largest shareholder in the global market and is expected to grow at the fastest CAGR during the forecast period. The U.S. and Canada are key contributors to North America's market share, with the U.S. generating the most revenue in the region. The presence of well-established conglomerates has fostered the growth of numerous startup companies, which are driving technological innovations in the global market. These startups receive substantial investments from conglomerates to support research projects aimed at developing disruptive sequencing technologies. Furthermore, universities and government organizations are making significant investments to fund research projects that enhance the efficiency, feasibility, and affordability of carrier screening tests.
To maintain competitiveness, key players in the reproductive genome market employ various strategies such as forming strategic partnerships with fertility clinics and healthcare providers to improve accessibility. Additionally, companies invest in research and development to stay ahead of emerging trends and implement robust marketing and educational campaigns to raise awareness and attract customers. Some companies also focus on providing personalized genetic counseling and support services to distinguish themselves in the market.
In December 2023, Orchid, a reproductive technology startup, introduced the first commercially available whole genome sequencing test for embryos. This groundbreaking test can detect birth defects, neurodevelopmental disorders, chromosomal abnormalities, and both pediatric and adult-onset cancers before pregnancy begins.
GLOBAL REPRODUCTIVE GENETICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Agilent
BGI
CENTOGENE
Fulgent Genetics
Roche
Laboratory Corporation of America
PerkinElmer
Myriad Genetics
Quest Diagnostics
QIAGEN
Igenomix
Illumina
Thermo Fisher Scientific
Others